1-1 of 1
Candace F Shelton
Close
Sort by
Journal Articles

Phase I Study of Novel Prodrug Dual PI3K/mTOR Inhibitor SF1126 In B-Cell Malignancies.

Joseph R Garlich, PhD, Michael D Becker, Candace F Shelton, Wenqing Qi, PhD, Xiaobing Liu, Laurence Cooke, Daruka Mahadevan, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1783.
https://doi.org/10.1182/blood.V116.21.1783.1783
Published: 2010